Aprepitant 80 MG capsule 6S
Ended Awarded Last action
- Contract number
- SPE2DR26F5T22
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,792
Award facts
- Contract value 100% obligated
- $1,792.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,792.44 delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules (6-count units) under a firm fixed price contract. This non-set-aside award was issued on December 12, 2025, with an ultimate completion date of December 15, 2025. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military and federal healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company has demonstrated capability to fulfill federal requirements through open competition across a diverse portfolio of pharmaceutical products and medical supplies. Aprepitant, an antiemetic medication commonly used in cancer treatment and chemotherapy support, represents one of the specialized pharmaceutical products within the company's extensive federal contract portfolio, which includes brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5T22?
SPE2DR26F5T22 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26F5T22 worth?
The government has obligated $1,792 on SPE2DR26F5T22.
Is contract SPE2DR26F5T22 an order under another contract?
Yes. SPE2DR26F5T22 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5T22 competed?
The extent of competition for SPE2DR26F5T22 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award